Valuation: Lifestyle Delivery Systems Inc

Market Cap 10.2M 7.24M 6.36M 5.91M 5.43M 697M 10.36M 70.24M 27.44M 343M 27.18M 26.6M 1.19B P/E 2022 *
-
P/E 2023 -0.92x
Enterprise Value 9.74M 6.92M 6.08M 5.65M 5.18M 666M 9.89M 67.09M 26.21M 327M 25.97M 25.41M 1.13B EV / Sales 2022 *
-
EV / Sales 2023 43x
Free-Float
99.7%
Yield 2022 *
-
Yield 2023 -
Change 5-day change 1-year change 3-year change Capi.($)
-10.84%-40.80% - - 47
-1.35%-0.82%-10.59%-4.17% 13.62B
-2.94%-3.76%-31.42%-51.83% 5.23B
-0.78%+1.50%-1.38%-2.62% 4.83B
-3.19%-0.61%+1.11%-32.57% 4.18B
-2.43%-3.43%+0.94%-10.97% 3.71B
-1.33%+1.56%-2.63%-4.79% 3.68B
-1.19%+2.47%-3.08%+10.29% 3.52B
-2.28%-0.77%-14.27%-23.60% 2.46B
-3.10%-2.19%-5.97%+39.02% 1.88B
Average -2.94%-3.10%-7.48%-9.03% 4.79B
Weighted average by Cap. -1.86%-2.85%-8.67%-11.21%

Financials

2021 2022 *
Net sales 432K 306K 269K 250K 230K 29.51M 438K 2.97M 1.16M 14.51M 1.15M 1.13M 50.17M -
Net income -37.05M -26.31M -23.11M -21.49M -19.72M -2.53B -37.63M -255M -99.71M -1.25B -98.78M -96.65M -4.31B -
Net Debt -843K -599K -526K -489K -449K -57.67M -856K -5.81M -2.27M -28.35M -2.25M -2.2M -98.03M -
Logo Lifestyle Delivery Systems Inc
Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.
Employees
-